Background illustration for clinical trials search

Autoimmune Disorders Clinical Trials

Browse 881 autoimmune disorders clinical trials enrolling across the United States and Canada. 117 people applied to autoimmune disorders studies last month. Search by city or state to find one near you.

Filter
1
Active & Responsive

Behavioral Approaches to Reduce Diabetes Distress in Adults With Type 1 Diabetes: A Pragmatic SMART

for
Diabetes type1, Diabetes Mellitus, Type 1, Diabetes, Autoimmune,
Location: Chapel Hill NC
Sponsor: University of North Carolina, Chapel Hill

Sex: All

Age: 30+

Code: NCT06405373

Recruiting
Active & Responsive

Ublituximab (Briumvi) for Early Forms of Relapsing Multiple Sclerosis

for
Multiple Sclerosis,
Location: Chicago IL
Sponsor: Northwestern University

Sex: All

Age: 18 - 70

Code: NCT07225361

Recruiting
Active & Responsive

Transcutaneous Vagus Nerve Stimulation in SLE

for
Systemic Lupus Erythematosus
Location: Manhasset NY
Sponsor: Northwell Health

Sex: All

Age: 18+

Code: NCT06987565

Phase 2, Recruiting
Active & Responsive

A Phase IIa Study of ICG318 CAR-T in Refractory Systemic Lupus Erythematosus With or Without Lupus Nephritis

for
Systemic Lupus Erythematosus (SLE), Lupus Nephritis (LN)
Location: New Hyde Park NY
Sponsor: iCell Gene Therapeutics

Sex: All

Age: 16 - 70

Code: NCT07328581

Phase 2, Recruiting
Active & Responsive

Platform Trial to Delay Stage 3 Diabetes: Comparing Teplizumab With ATG

for
Type 1 Diabetes Mellitus
Location: New Haven CT, New York NY, Pittsburgh PA,
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Sex: All

Age: 4 - 34

Code: NCT07216391

Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

Cannabis (THC vs. CBD) in Multiple Sclerosis

for
Multiple Sclerosis
Location: Calgary
Sponsor: University of Calgary

Sex: All

Age: 26 - 59

Code: NCT06261489

Phase 2, Recruiting
Active & Responsive

Feasibility of Remote Monitoring of Patients With Myasthenia Gravis

for
Myasthenia Gravis (MG)
Location: Washington D.C. DC
Sponsor: George Washington University

Sex: All

Age: 18+

Code: NCT07787247

Recruiting
Active & Responsive

Roll-over Study for Participants Who Have Completed a Previous Clinical Study With Benralizumab (Fasenra) and Benefit From Continued Treatment

for
Asthma, Eosinophilic Granulomatosis With Polyangiitis (EGPA),
Location: Toronto
Sponsor: AstraZeneca

Sex: All

Age: 6+

Code: NCT07444567

Phase 3, Recruiting
Active & Responsive

Single Arm Trial Identifying Barriers and Facilitators to Mindfulness Practice

for
Multiple Sclerosis
Location: Seattle WA
Sponsor: University of Washington

Sex: All

Age: 18+

Code: NCT07573241

Recruiting
Active & Responsive

Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden

for
Sjögren´s Disease
Location: Sydney, Rimouski, Boston MA, Sherbrooke,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07621809

Phase 3, Recruiting
Active & Responsive

Simultaneous Measurement and Responsive Treatment - Part 2

for
Type 1 Diabetes Mellitus, T1D, Type 1 Diabetes, T1DM
Location: Toronto
Sponsor: ClinSurge Research

Sex: All

Age: 18+

Code: NCT07655076

Early Phase 1, Recruiting
Active & Responsive

A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC PFS in Adult Participants With Graves' Disease

for
Graves' Disease, Graves Disease
Location: New York NY, Albany NY, Raleigh NC, Fort Lauderdale FL,
Sponsor: argenx

Sex: All

Age: 18+

Code: NCT07570316

Phase 3, Recruiting
Active & Responsive

Thrive With Type 1 Diabetes 2026

for
Type1diabetes
Location: Atlanta GA
Sponsor: Emory University

Sex: All

Age: 31 - 70+

Code: NCT07522866

Recruiting
Active & Responsive

Mathematical Modeling of Blood Sugar and Hormone Responses in Insulin-Dependent Type 2 Diabetes

for
Type 2 Diabetes, Insulin Dependent Diabetes
Location: Chicago IL
Sponsor: Clinical Nutrition Research Center, Illinois Institute of Technology

Sex: All

Age: 18 - 65

Code: NCT07650682

Recruiting
Active & Responsive

A Study to Assess the Tolerability of Ianalumab (VAY736) With Investigator's Choice Thrombopoietin Receptor Agonist (IC TPO-RA) in Patients With Primary Immune Thrombocytopenia (ITP)

for
Primary Immune Thrombocytopenia (ITP),
Location: New Haven CT, Stamford CT, The Bronx NY, Summit NJ,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07421167

Phase 2, Recruiting
Active & Responsive

Direct to Patient Minimal Risk Biospecimen and Data Collection Research

for
Healthy, Lupus, Celiac, Kidney Disease, Chronic, Dermatologic
Location: Lexington MA
Sponsor: Joined Bio

Sex: All

Age: 18 - 70+

Code: NCT07128966

Recruiting
Active & Responsive

A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes

for
Type 1 Diabetes, New Onset
Location: New Haven CT, Miami FL, Buffalo NY, Pittsburgh PA,
Sponsor: City of Hope Medical Center

Sex: All

Age: 9 - 20

Code: NCT07061574

Phase 1, Phase 2, Recruiting
Active & Responsive

Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease

for
Primary Sjogren's Disease
Location: Boston MA, Philadelphia PA, Willow Grove PA,
Sponsor: Vor Biopharma

Sex: All

Age: 18 - 70+

Code: NCT07404865

Phase 3, Recruiting
Active & Responsive

Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus

for
Type 1 Diabetes Mellitus
Location: Boston MA, New Haven CT, New York NY, Miami FL,
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Sex: All

Age: 8 - 45

Code: NCT07142252

Phase 2, Recruiting
Active & Responsive

NEPTUNE Match Study

for
Nephrotic Syndrome in Children,
Location: New Hyde Park NY, New York NY, Philadelphia PA,
Sponsor: University of Michigan

Sex: All

Age: 1 - 70+

Code: NCT04571658

Recruiting